FDA IS URGED TO PULL ORTHO EVRA


	You will be connected directly to a DrugSettlement representative.

warning: Parameter 2 to flowplayer3_swftools_flashvars() expected to be a reference, value given in /var/www/pressflow/includes/module.inc on line 450.

Do you believe that you have a claim? Fill out this form to have a lawyer contact you.

Your name: *	Your email address: *	Cause of Injury: *
Your address (part 1):	(part 2):	City:
Zip: State: *	Phone#: *	How did you find DrugSettlement.com?: *
Please enter any information you'd like us to know: *

Thu, May 8, 2008

Ortho Evra is again under attack because of its increased risks of serious blood clots, pulmonary embolism, deep vein thrombosis and death among young women who use the product.

Reuters is reporting that Public Citizen's Helath Research Group has filed a petition with the FDA urging them to remove Johson & Johnson's Ortho Evra birth control patch from the market.

See: http://www.reuters.com/article/governmentFilingsNews/idUSN0730243920080508 .

In its petition Public Citizen claiming to represent more than 80,000 consumers nationwide, http://action.citizen.org/t/6578/content.jsp?content_KEY=4137, "petitions the Food and Drug Administration (FDA), pursuant to the Federal Food, Drug and Cosmetic Act 21 U.S.C. Section 355(e)(3) and 21 C.F.R. 10.30, to ban the transdermal contraceptive patch, Ortho-Evra (ethinyl estradiol/norelgestromin, Johnson & Johnson), with market removal of the device to occur within 6 months."